Dec 31, 2025 • Insider Monkey
SOMEWHAT-BULLISH
What Makes The Cooper Companies (COO) an Investment Bet?
Diamond Hill Capital's Mid Cap Strategy initiated a position in The Cooper Companies (NASDAQ: COO) during Q3 2025, viewing it as an attractive investment despite current transitory headwinds. The company, a leader in contact lenses and women's health, is expected to benefit from long-term growth in its markets. While Cooper Companies isn't among the top 30 hedge fund picks, 56 hedge funds held positions at the end of Q3, indicating significant institutional interest.
Dec 30, 2025 • MarketBeat
BULLISH
First American Bank Takes $1.65 Million Position in The Cooper Companies, Inc. $COO
First American Bank recently acquired 24,011 shares of The Cooper Companies (NASDAQ:COO) worth $1.65 million during the third quarter, making it a new institutional investor. The Cooper Companies has shown strong financial performance, beating Q3 earnings and revenue estimates, and announced a $2 billion share buyback program. Analyst ratings are mixed, with a "Moderate Buy" consensus and an average price target of $90.15.
Dec 30, 2025 • TradingView — Track All Markets
NEUTRAL
Reasons to Add Cooper Companies Stock to Your Portfolio Now
The Cooper Companies (COO) is experiencing growth due to the success of its CooperVision's MyDay lens and its MiSight myopia-management product, along with its CooperSurgical women's health portfolio. Despite some near-term challenges like channel volatility and tariff pressures, the company is implementing reorganization efforts to drive margin expansion and strong cash flow. These factors, combined with a shareholder-friendly capital allocation strategy, make COO an attractive investment.
Dec 30, 2025 • MSN
SOMEWHAT-BULLISH
BofA Slashes Price Target on Cooper Companies (COO), Keeps Buy Rating
BofA Securities has reiterated its Buy rating on Cooper Companies (COO) but adjusted its price target down to $110 from $120. This update follows their analysis of the company's performance and outlook. Despite the reduced price target, the firm maintains a positive long-term view of Cooper Companies.
Dec 30, 2025 • Stock Titan
NEUTRAL
Medical device maker CooperCompanies joins J.P. Morgan health summit
CooperCompanies (Nasdaq: COO) will present at the J.P. Morgan Healthcare Conference on January 14, 2026, with President and CEO Al White speaking at 5:15pm ET. A live and archived webcast will be available on the company's investor website. This participation is part of ongoing investor communications following solid fiscal 2025 results and strategic initiatives.
Dec 29, 2025 • FinancialContent
NEUTRAL
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
CooperCompanies (Nasdaq: COO) announced its participation in the J.P. Morgan Healthcare Conference scheduled for Wednesday, January 14, 2026. Al White, President and CEO, will represent the company, with a session starting at 5:15 PM ET. A webcast of the event will be available on the CooperCompanies' investor relations website.